VRA:NASDAQVera Bradley, Inc. Analysis
Data as of 2026-09-01 - not real-time
$3.40
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Vera Bradley, Inc. is neutral at $3.40, with no clear ordering between short and long averages. Over a rolling month the price has lost 9.3%. Momentum indicators put RSI at 51.4 (neutral) with MACD reading bullish. Price has been bracketed by support at $3.04 and resistance at $3.61.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 47.1% above where the shares trade now. Revenue is growing at 7.8% on a -7.0% profit margin.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 37.9%, a beta of 0.81 and a maximum drawdown of 40.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 47.1% above where the shares trade now. Revenue is growing at 7.8% on a -7.0% profit margin.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 37.9%, a beta of 0.81 and a maximum drawdown of 40.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 3.18
- MACD momentum is positive
- 30-day price change of -9.3%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 3.18
- Analyst targets imply +47.1% versus the current price
- MACD momentum is positive
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -7.0%
- Analyst targets imply +47.1% versus the current price
- Negative return on equity of -14.1%
Key Metrics & Analysis
Financial Health
Revenue Growth7.80%
Profit Margin-7.02%
P/E Ratio-113.3
ROE-14.09%
ROA-3.71%
Debt/Equity51.38
P/B Ratio0.8
Op. Cash Flow$2.7M
Free Cash Flow$28.5M
Technical Analysis
TrendNeutral
RSI51.4
Support$3.04
Resistance$3.61
MA 20$3.31
MA 50$3.60
MA 200$3.18
MACDBullish
VolumeDecreasing
Fear & Greed Index94.79
Valuation
Fair Value$15.89
Target Price$5.00
Upside/Downside47.06%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.81
Volatility37.92%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.